MetS, including obesity, cardiovascular disease, type 2 diabetes, and neurodegenerative disorders, is associated with the regulation of adiponectin expression [8,45,46]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.